Skip to main content
Medicine logoLink to Medicine
. 2021 Jan 29;100(4):e24546. doi: 10.1097/MD.0000000000024546

Effectiveness and safety of Hwangryunhaedok-Tang (Huang-Lian-Jie-Du-Tang, Oren-Gedoku-to) for dyslipidemia: A protocol for a PRISMA-compliant systematic review and meta-analysis: Erratum

PMCID: PMC7850740  PMID: 33530284

In the article, “Effectiveness and safety of Hwangryunhaedok-Tang (Huang-Lian-Jie-Du-Tang, Oren-Gedoku-to) for dyslipidemia: A protocol for a PRISMA-compliant systematic review and meta-analysis”,[1] the title was first published incorrectly and has since been changed to “Effectiveness and safety of Hwangryunhaedok-Tang (Huang-Lian-Jie-Du-Tang, Oren-Gedoku-to) for dyslipidemia: A PRISMA-compliant systematic review and meta-analysis.”

Footnotes

How to cite this article: Lee B, Kwon C-Y. Effectiveness and safety of Hwangryunhaedok-Tang (Huang-Lian-Jie-Du-Tang, Oren-Gedoku-to) for dyslipidemia: A protocol for a PRISMA-compliant systematic review and meta-analysis. Medicine. 2021;100:4(e24546).

Reference

  • [1].Lee B, Kwon C-Y. Effectiveness and safety of Hwangryunhaedok-Tang (Huang-Lian-Jie-Du-Tang, Oren-Gedoku-to) for dyslipidemia: A protocol for a PRISMA-compliant systematic review and meta-analysis. Medicine. 2020. 99:e23367. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES